Issue 47, 2011

Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery

Abstract

Cationic polymer polyethyleneimine (PEI) can carry DNA across the cell membrane and enter the nucleus, and thus can be a very useful carrier for nuclear drug delivery; however, its highly positive charges make it toxic and not applicable for systemic drug delivery. Here, well-defined linear PEI (Mn = 1000 or 1500 or 2000)-block-polycaprolactone (Mn = 2000) (LPEI–PCL) was synthesized and used to fabricate a pH-triggered charge-reversal nanoparticle to solve this problem. LPEI's secondary amines are amidized as acid-labile β-carboxylic amides (LPEI/amide–PCL). LPEI/amide–PCL formed negatively charged nanoparticles with very low toxicity and low interaction with cells. Once in an acidic environment, the amides hydrolyze to regenerate the amine groups, producing LPEI–PCL nanoparticles carrying cationic charges. The LPEI–PCL escapes from the lysosomes and traverses into the nucleus. Folic-acid targeting groups are introduced to render the nanoparticles cancer-cell targeting capability. The nanoparticles efficiently enter folate-receptor overexpressing cancer cells and traverse to their nuclei. The DOX loaded in the carrier shows much improved cytotoxicity to cancer cells.

Graphical abstract: Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery

Article information

Article type
Paper
Submitted
27 Jul 2011
Accepted
23 Sep 2011
First published
26 Oct 2011

J. Mater. Chem., 2011,21, 19114-19123

Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery

Z. Zhou, Y. Shen, J. Tang, E. Jin, X. Ma, Q. Sun, B. Zhang, E. A. Van Kirk and W. J. Murdoch, J. Mater. Chem., 2011, 21, 19114 DOI: 10.1039/C1JM13576G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements